JP2023517293A5 - - Google Patents
Info
- Publication number
- JP2023517293A5 JP2023517293A5 JP2022552793A JP2022552793A JP2023517293A5 JP 2023517293 A5 JP2023517293 A5 JP 2023517293A5 JP 2022552793 A JP2022552793 A JP 2022552793A JP 2022552793 A JP2022552793 A JP 2022552793A JP 2023517293 A5 JP2023517293 A5 JP 2023517293A5
- Authority
- JP
- Japan
- Prior art keywords
- side chains
- seq
- bridged
- amino acid
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062985100P | 2020-03-04 | 2020-03-04 | |
| US62/985,100 | 2020-03-04 | ||
| PCT/US2021/020940 WO2021178714A2 (en) | 2020-03-04 | 2021-03-04 | ANTIVIRAL STRUCTURALLY-STABILIZED SARS-CoV-2 PEPTIDES AND USES THEREOF |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023517293A JP2023517293A (ja) | 2023-04-25 |
| JP2023517293A5 true JP2023517293A5 (enExample) | 2024-09-12 |
| JP7894318B2 JP7894318B2 (ja) | 2026-07-23 |
Family
ID=75223491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022552793A Active JP7894318B2 (ja) | 2020-03-04 | 2021-03-04 | 抗ウイルスの構造的に安定化されたＳＡＲＳ－ＣｏＶ－２ペプチドおよびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240124529A1 (enExample) |
| EP (1) | EP4114431A2 (enExample) |
| JP (1) | JP7894318B2 (enExample) |
| KR (1) | KR20220148869A (enExample) |
| CN (1) | CN115811984A (enExample) |
| AU (1) | AU2021230544A1 (enExample) |
| CA (1) | CA3173973A1 (enExample) |
| WO (1) | WO2021178714A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023524911A (ja) * | 2020-04-24 | 2023-06-13 | ザ トラスティース オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク | Ｓａｒｓ－ｃｏｖ－２抗ウイルス薬としての脂質－ペプチド融合物阻害剤 |
| CN113817026B (zh) * | 2021-09-16 | 2023-06-30 | 中国人民解放军海军军医大学 | 靶向刺突蛋白hr1的订书肽、制备方法及抗新型冠状病毒应用 |
| CN113773370B (zh) * | 2021-10-15 | 2022-07-22 | 哈尔滨吉象隆生物技术有限公司 | 一种抗病毒的多肽及其应用 |
| US20260232759A1 (en) * | 2021-10-22 | 2026-08-13 | Wisconsin Alumni Research Foundation | Peptides that inhibit infection by sars-cov-2, the virus that causes covid-19 disease |
| CN114437196A (zh) * | 2022-02-16 | 2022-05-06 | 复旦大学 | 一种抑制SARS-CoV-2感染的蛋白及其用途 |
| EP4611789A1 (en) * | 2022-11-06 | 2025-09-10 | Leyden Laboratories B.V. | Sars-cov-2 binding polypeptide |
| WO2024186980A2 (en) * | 2023-03-08 | 2024-09-12 | Dana-Farber Cancer Institute, Inc. | Hendra virus and nipah virus surface glycoprotein peptides, conjugates, and uses thereof |
| WO2025235945A1 (en) * | 2024-05-10 | 2025-11-13 | Red Queen Therapeutics, Inc. | Methods of treating viral infections using a fusion inhibitor |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5446090A (en) | 1993-11-12 | 1995-08-29 | Shearwater Polymers, Inc. | Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
| US20020064546A1 (en) | 1996-09-13 | 2002-05-30 | J. Milton Harris | Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor |
| ES2211033T3 (es) | 1998-01-07 | 2004-07-01 | Debio Recherche Pharmaceutique S.A. | Acrilatos de polietilenglicol heterobifuncionales degradables y geles y conjugados derivados de dichos acrilatos. |
| US6348558B1 (en) | 1999-12-10 | 2002-02-19 | Shearwater Corporation | Hydrolytically degradable polymers and hydrogels made therefrom |
| BR0001870B1 (pt) | 2000-05-29 | 2014-02-25 | Peptídeo, processo de obtenção de peptídeo, formulação compreendendo peptídeo, método de prevenção de crescimento de parasitas, fungos e bactérias, método para inativar a endotoxina de bactérias gram-negativas | |
| EP1680443B9 (en) | 2003-11-05 | 2014-09-03 | Dana-Farber Cancer Institute, Inc. | Stabilized alpha helical peptides and uses thereof |
| US20080027006A1 (en) | 2004-02-12 | 2008-01-31 | The Regents Of The University Of Colorado | Compositions And Methods For Modification And Prevention Of Sars Coronavirus Infectivity |
| US7491489B2 (en) * | 2004-11-22 | 2009-02-17 | The University Of Hong Knog | Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof |
| WO2007005249A2 (en) * | 2005-06-29 | 2007-01-11 | Hyperbranch Medical Technology, Inc. | Nanoparticles and dendritic-polymer-based hydrogels comprising them |
| EP2508531B1 (en) | 2007-03-28 | 2016-10-19 | President and Fellows of Harvard College | Stitched polypeptides |
| EP2208061B1 (en) | 2007-09-26 | 2017-11-08 | Dana Farber Cancer Institute | Methods and compositions for modulating bcl-2 family polypeptides |
| JP5788178B2 (ja) | 2008-01-23 | 2015-09-30 | ダナ ファーバー キャンサー インスティテュート インコーポレイテッド | ウィルス感染症の治療のための組成物及び方法 |
| JP2011522796A (ja) * | 2008-05-06 | 2011-08-04 | ニューヨーク ブラッド センター， インコーポレイテッド | 抗ウイルス細胞透過性ペプチド |
| WO2010060112A1 (en) | 2008-11-24 | 2010-05-27 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles with improved properties |
| EP3549951A3 (en) | 2008-12-09 | 2019-11-20 | Dana Farber Cancer Institute, Inc. | Methods and compositions for specific modulation of mcl-1 |
| EP2376100B1 (en) * | 2009-01-14 | 2017-10-25 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| EP3698811A1 (en) | 2009-06-18 | 2020-08-26 | Dana Farber Cancer Institute, Inc. | Structured viral peptide compositions and methods of use |
| CN102939101A (zh) * | 2010-01-26 | 2013-02-20 | 科罗拉多大学董事会，法人 | 用于通用疫苗的流感病毒组合物和方法 |
| GB2473525B (en) | 2010-07-19 | 2011-07-27 | Alexander P Fisher | System and method for growing plants |
| WO2014055564A1 (en) * | 2012-10-01 | 2014-04-10 | President And Fellows Of Harvard College | Stabilized polypeptide insulin receptor modulators |
| EP3782638A1 (en) * | 2013-03-13 | 2021-02-24 | President and Fellows of Harvard College | Stapled and stitched polypeptides and uses thereof |
| CN107022008B (zh) | 2016-01-30 | 2021-04-23 | 山西锦波生物医药股份有限公司 | 广谱地抑制人类冠状病毒感染的多肽及其应用 |
| US20190048038A1 (en) | 2016-02-23 | 2019-02-14 | Dana-Farber Cancer Institute, Inc. | Method for generating cell-penetrating stapled peptides that lack nonspecific membrane-lytic properties for therapeutic targeting |
| US10004200B1 (en) * | 2017-05-08 | 2018-06-26 | Pioneer Hi-Bred International, Inc. | Soybean variety P000A87R |
| CN108395471B (zh) * | 2018-01-15 | 2020-03-13 | 中国人民解放军军事科学院军事医学研究院 | 抑制MERS-CoV感染的多肽 |
-
2021
- 2021-03-04 JP JP2022552793A patent/JP7894318B2/ja active Active
- 2021-03-04 EP EP21714561.4A patent/EP4114431A2/en active Pending
- 2021-03-04 KR KR1020227033763A patent/KR20220148869A/ko active Pending
- 2021-03-04 WO PCT/US2021/020940 patent/WO2021178714A2/en not_active Ceased
- 2021-03-04 CN CN202180032678.6A patent/CN115811984A/zh active Pending
- 2021-03-04 US US17/908,825 patent/US20240124529A1/en active Pending
- 2021-03-04 CA CA3173973A patent/CA3173973A1/en active Pending
- 2021-03-04 AU AU2021230544A patent/AU2021230544A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025166834A5 (enExample) | ||
| FI92210C (fi) | Menetelmä farmaseuttisesti käyttökelpoisten GRF-analogien valmistamiseksi | |
| CA2370289A1 (en) | Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides | |
| EP1098906A1 (en) | Peptide analogues of pacap | |
| JPS62259598A (ja) | 線維芽細胞発育因子きつ抗物質 | |
| ATE350049T1 (de) | Zusammensetzungen und verfahren zur behinderung der vervielfältigung von hiv-1 | |
| FI91074C (fi) | Menetelmä terapeuttisesti käyttökelpoisen rengasrakenteen sisältävän GRF-analogin valmistamiseksi | |
| WO1997031019B1 (en) | Antipathogenic peptides and compositions comprising them | |
| JPH0291098A (ja) | 生長ホルモン放出因子ペプチド | |
| DK2783697T3 (en) | VIP Fragments and uses thereof | |
| WO2019136824A1 (zh) | 抑制MERS-CoV感染的多肽 | |
| JP2023116739A5 (enExample) | ||
| JP2025172140A5 (enExample) | ||
| JP2006523709A5 (enExample) | ||
| FI81589B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara grf-peptidanaloger. | |
| CN88103015A (zh) | 环状抗凝血剂肽 | |
| US3864481A (en) | Anti disease producing synthetic material for the prevention suppression and diagnosis of multiple sclerosis and method of treatment therefor | |
| WO1993003766A1 (en) | Multiple antigen peptides for use as hiv vaccines | |
| CN1041157A (zh) | 肽醇抗血凝剂 | |
| JPS58206545A (ja) | 免疫調節ペプチド | |
| CH633566A5 (en) | Process for the preparation of a novel polypeptide which reduces the levels of serum calcium | |
| ABIKO et al. | The effect of thymopoietin II fragments and their analogs on E-rosette forming cells in the uremic state | |
| CN1030255C (zh) | 环形生长激素释放因子(grf)类似物的制备方法 | |
| RU2263679C2 (ru) | Агонисты и антагонисты уротензина-ii | |
| DE69117965D1 (de) | Peptide, welche hiv-retroviren-hemmende antikörper induzieren, sowie gegen diese peptide gerichtete antikörper |